| 产品名称: | Leishmania major (Yakimoff and Schokhor) Bray et al. |
|---|---|
| 商品货号: | TS133482 |
| Deposited As: | Leishmania major Δgp63 1-7 + gp63 gene 1 NIH SD (MHOM/SN/74/SD) |
| Strain Designations: | (MHOM/SN/74/SD) Δgp63 1-7 + gp63 1 |
| Application: | Virulence and vaccine studies |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation: | Cutaneous leishmaniasis, Senegal, 1973 |
| Product Format: | frozen |
| Storage Conditions: | Frozen: -70°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Protocols Section |
| Type Strain: | no |
| Comments: | Leishmanolysin-deficient mutant lacking gp63 genes 1-7. Complemented with gp63 gene 1 by transfection. Ref![]() Joshi, PB, et al. Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol. Biochem. Parasitol. 120: 33-40, 2002. PubMed: 11849703 |
| Medium: | ATCC® Medium 2736: M199, Modified Medium ATCC® Medium 1011: Diphasic blood agar medium ATCC® Medium 807: Brain heart infusion blood agar |
| Growth Conditions: | Temperature: 20°C to 25°C |
| Cryopreservation: | Harvest and Preservation
|
| Name of Depositor: | R McMaster |
| Chain of Custody: | ATCC |
| References: | Neva FA, et al. Cutaneous leishmaniasis--a case with persistent organisms after treatment in presence of normal immune response. Am. J. Trop. Med. Hyg. 28: 467-71, 1979. PubMed: 222157 McDowell, MA, et al. Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect. Immun. 70: 3994-4001, 2002. PubMed: 12117904 Joshi, PB, et al. Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol. Biochem. Parasitol. 120: 33-40, 2002. PubMed: 11849703 |
| 产品名称: | Leishmania major (Yakimoff and Schokhor) Bray et al. |
|---|---|
| 商品货号: | TS133482 |
| Deposited As: | Leishmania major Δgp63 1-7 + gp63 gene 1 NIH SD (MHOM/SN/74/SD) |
| Strain Designations: | (MHOM/SN/74/SD) Δgp63 1-7 + gp63 1 |
| Application: | Virulence and vaccine studies |
| Biosafety Level: | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation: | Cutaneous leishmaniasis, Senegal, 1973 |
| Product Format: | frozen |
| Storage Conditions: | Frozen: -70°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Protocols Section |
| Type Strain: | no |
| Comments: | Leishmanolysin-deficient mutant lacking gp63 genes 1-7. Complemented with gp63 gene 1 by transfection. Ref![]() Joshi, PB, et al. Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol. Biochem. Parasitol. 120: 33-40, 2002. PubMed: 11849703 |
| Medium: | ATCC® Medium 2736: M199, Modified Medium ATCC® Medium 1011: Diphasic blood agar medium ATCC® Medium 807: Brain heart infusion blood agar |
| Growth Conditions: | Temperature: 20°C to 25°C |
| Cryopreservation: | Harvest and Preservation
|
| Name of Depositor: | R McMaster |
| Chain of Custody: | ATCC |
| References: | Neva FA, et al. Cutaneous leishmaniasis--a case with persistent organisms after treatment in presence of normal immune response. Am. J. Trop. Med. Hyg. 28: 467-71, 1979. PubMed: 222157 McDowell, MA, et al. Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect. Immun. 70: 3994-4001, 2002. PubMed: 12117904 Joshi, PB, et al. Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol. Biochem. Parasitol. 120: 33-40, 2002. PubMed: 11849703 |